[1] BJOERN MOOSMANN. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics[J]. Journal of Mass Spectrometry, 2013, 48 11: 1150-1159. DOI:
10.1002/jms.3279[2] JONES L E, STEWART A, PETERS K L, et al. Infrared and Raman screening of seized novel psychoactive substances: a large scale study of >200 samples?[J]. Analyst, 2016, 3: 902-909. DOI:
10.1039/c5an02326b[3] RACHELLE ABOUCHEDID. Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK.[J]. Journal of Medical Toxicology, 2018, 14 2: 134-143. DOI:
10.1007/s13181-018-0659-3